Synthesis and characterization of Gd
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 03 2023
18 03 2023
Historique:
received:
22
12
2022
accepted:
08
03
2023
entrez:
19
3
2023
pubmed:
20
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
Magnetic resonance imaging and computed tomography (CT) suffer from low contrast sensitivity and potential toxicity of contrast agents. To overcome these limitations, we developed and tested a new class of dual contrast agents based on polydopamine nanoparticles (PDA-NPs) that are functionalized and targeted with hyaluronic acid (HA). These nanoparticles (NPs) are chelated with Gd
Identifiants
pubmed: 36934115
doi: 10.1038/s41598-023-31252-0
pii: 10.1038/s41598-023-31252-0
pmc: PMC10024681
doi:
Substances chimiques
polydopamine
0
gadoterate meglumine
L0ND3981AG
Contrast Media
0
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4520Informations de copyright
© 2023. The Author(s).
Références
Methods Mol Biol. 2011;697:35-52
pubmed: 21116952
Curr Mol Imaging. 2012 Oct 1;1(1):12-25
pubmed: 23316452
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
Chem Soc Rev. 2006 Jun;35(6):557-71
pubmed: 16729149
J Am Chem Soc. 2003 May 7;125(18):5471-8
pubmed: 12720461
ACS Appl Mater Interfaces. 2015 Aug 12;7(31):16946-52
pubmed: 26196160
J Am Chem Soc. 2008 May 7;130(18):5908-15
pubmed: 18407638
Chem Cent J. 2017 May 30;11(1):47
pubmed: 29086824
Int Immunopharmacol. 2022 Apr;105:108585
pubmed: 35131732
Sci Rep. 2018 Mar 13;8(1):4393
pubmed: 29535354
Biomimetics (Basel). 2018 Sep 13;3(3):
pubmed: 31105248
Drug Res (Stuttg). 2014 Feb;64(2):57-65
pubmed: 24310361
Biochem Biophys Rep. 2021 Apr 10;26:100991
pubmed: 33912692
Sci Rep. 2015 Nov 18;5:16214
pubmed: 26577829
Bioact Mater. 2020 Jun 21;5(4):758-767
pubmed: 32637740
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1111-1121
pubmed: 28933183
Clin Chest Med. 2008 Mar;29(1):195-216, vii
pubmed: 18267192
Radiology. 2014 Mar;270(3):834-41
pubmed: 24475844
Tetrahedron. 2011 Nov 4;67(44):8431-8444
pubmed: 22043109
Chem Rev. 2019 Jan 23;119(2):957-1057
pubmed: 30350585
Materials (Basel). 2020 Apr 07;13(7):
pubmed: 32272786
Radiology. 2015 Jun;275(3):783-91
pubmed: 25848905
ACS Nano. 2012 Nov 27;6(11):9522-31
pubmed: 23092111
J Phys Chem B. 2019 Mar 21;123(11):2513-2524
pubmed: 30813731
J Mater Chem B. 2013 Nov 14;1(42):5791-5797
pubmed: 32261236
Cancer Nanotechnol. 2014;5(1):4
pubmed: 26561512
ACS Omega. 2021 Nov 24;6(48):32342-32348
pubmed: 34901587
Chem Rev. 2015 Oct 14;115(19):10967-1011
pubmed: 26463640
ACS Appl Mater Interfaces. 2016 Aug 24;8(33):21585-94
pubmed: 27472008
MethodsX. 2019 Jan 10;6:156-161
pubmed: 30733928
Adv Drug Deliv Rev. 2020;154-155:102-122
pubmed: 32650041
Nanomaterials (Basel). 2021 Sep 20;11(9):
pubmed: 34578765
Radiology. 1989 Apr;171(1):77-80
pubmed: 2928549
Nanotechnology. 2013 Nov 22;24(46):462001
pubmed: 24158750
Adv Mater. 2014 Oct 22;26(39):6761-6766
pubmed: 25178894
Biomacromolecules. 2012 Aug 13;13(8):2554-61
pubmed: 22804331
J Control Release. 2019 Apr 10;299:31-43
pubmed: 30797868
J Cell Mol Med. 2020 Apr;24(7):3779-3794
pubmed: 32154648
Acta Pharm Sin B. 2019 Mar;9(2):397-409
pubmed: 30972285